High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity

ObjectiveA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased char...

Full description

Saved in:
Bibliographic Details
Published in:Gut Vol. 69; no. 4; pp. 691 - 703
Main Authors: de Vries, Natasja L, van Unen, Vincent, Ijsselsteijn, Marieke E, Abdelaal, Tamim, van der Breggen, Ruud, Farina Sarasqueta, Arantza, Mahfouz, Ahmed, Peeters, Koen C M J, Höllt, Thomas, Lelieveldt, Boudewijn P F, Koning, Frits, de Miranda, Noel F C C
Format: Journal Article
Language:English
Published: England BMJ Publishing Group Ltd and British Society of Gastroenterology 01.04.2020
BMJ Publishing Group LTD
BMJ Publishing Group
Series:Original research
Subjects:
ISSN:0017-5749, 1468-3288, 1468-3288
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract ObjectiveA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC.DesignThirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence.ResultsWe discovered that a previously unappreciated innate lymphocyte population (Lin–CD7+CD127–CD56+CD45RO+) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103+CD69+) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR+CD38+PD-1+) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes.ConclusionThis work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting.
AbstractList ObjectiveA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC.DesignThirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence.ResultsWe discovered that a previously unappreciated innate lymphocyte population (Lin–CD7+CD127–CD56+CD45RO+) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103+CD69+) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR+CD38+PD-1+) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes.ConclusionThis work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting.
A comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC.OBJECTIVEA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC.Thirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence.DESIGNThirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence.We discovered that a previously unappreciated innate lymphocyte population (Lin-CD7+CD127-CD56+CD45RO+) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103+CD69+) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR+CD38+PD-1+) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes.RESULTSWe discovered that a previously unappreciated innate lymphocyte population (Lin-CD7+CD127-CD56+CD45RO+) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103+CD69+) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR+CD38+PD-1+) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes.This work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting.CONCLUSIONThis work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting.
A comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC. Thirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence. We discovered that a previously unappreciated innate lymphocyte population (Lin CD7 CD127 CD56 CD45RO ) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103 CD69 ) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR CD38 PD-1 ) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes. This work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting.
Author Lelieveldt, Boudewijn P F
Ijsselsteijn, Marieke E
Peeters, Koen C M J
Abdelaal, Tamim
Höllt, Thomas
van der Breggen, Ruud
de Vries, Natasja L
Farina Sarasqueta, Arantza
Mahfouz, Ahmed
van Unen, Vincent
Koning, Frits
de Miranda, Noel F C C
AuthorAffiliation 2 TECObiosciences GmbH , Landshut , Germany
1 Immunohematology and Blood Transfusion , Leiden University Medical Center , Leiden , Netherlands
7 Computer Graphics and Visualization , Delft University of Technology , Delft , The Netherlands
3 Pathology , Leiden University Medical Center , Leiden , The Netherlands
6 Surgery , Leiden University Medical Center , Leiden , The Netherlands
4 Pattern Recognition and Bioinformatics , Delft University of Technology , Delft , The Netherlands
5 Leiden Computational Biology Center , Leiden University Medical Center , Leiden , The Netherlands
8 LKEB Radiology , Leiden University Medical Center , Leiden , The Netherlands
AuthorAffiliation_xml – name: 8 LKEB Radiology , Leiden University Medical Center , Leiden , The Netherlands
– name: 4 Pattern Recognition and Bioinformatics , Delft University of Technology , Delft , The Netherlands
– name: 1 Immunohematology and Blood Transfusion , Leiden University Medical Center , Leiden , Netherlands
– name: 7 Computer Graphics and Visualization , Delft University of Technology , Delft , The Netherlands
– name: 2 TECObiosciences GmbH , Landshut , Germany
– name: 3 Pathology , Leiden University Medical Center , Leiden , The Netherlands
– name: 5 Leiden Computational Biology Center , Leiden University Medical Center , Leiden , The Netherlands
– name: 6 Surgery , Leiden University Medical Center , Leiden , The Netherlands
Author_xml – sequence: 1
  givenname: Natasja L
  orcidid: 0000-0003-4966-7036
  surname: de Vries
  fullname: de Vries, Natasja L
  organization: TECObiosciences GmbH, Landshut, Germany
– sequence: 2
  givenname: Vincent
  surname: van Unen
  fullname: van Unen, Vincent
  organization: Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands
– sequence: 3
  givenname: Marieke E
  surname: Ijsselsteijn
  fullname: Ijsselsteijn, Marieke E
  organization: Pathology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 4
  givenname: Tamim
  surname: Abdelaal
  fullname: Abdelaal, Tamim
  organization: Leiden Computational Biology Center, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 5
  givenname: Ruud
  surname: van der Breggen
  fullname: van der Breggen, Ruud
  organization: Pathology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 6
  givenname: Arantza
  surname: Farina Sarasqueta
  fullname: Farina Sarasqueta, Arantza
  organization: Pathology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 7
  givenname: Ahmed
  surname: Mahfouz
  fullname: Mahfouz, Ahmed
  organization: Leiden Computational Biology Center, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 8
  givenname: Koen C M J
  surname: Peeters
  fullname: Peeters, Koen C M J
  organization: Surgery, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 9
  givenname: Thomas
  surname: Höllt
  fullname: Höllt, Thomas
  organization: Computer Graphics and Visualization, Delft University of Technology, Delft, The Netherlands
– sequence: 10
  givenname: Boudewijn P F
  surname: Lelieveldt
  fullname: Lelieveldt, Boudewijn P F
  organization: LKEB Radiology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 11
  givenname: Frits
  surname: Koning
  fullname: Koning, Frits
  organization: Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands
– sequence: 12
  givenname: Noel F C C
  surname: de Miranda
  fullname: de Miranda, Noel F C C
  organization: Pathology, Leiden University Medical Center, Leiden, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31270164$$D View this record in MEDLINE/PubMed
BookMark eNqNks1uEzEUhS1URNPCC7BAI7FhM8XXHv9tkFAFLVIlNrC2PI4ncTRjF9sTKW9fh7QBuojwxrL8netzfc8FOgsxOITeAr4CoPzjai6bMLYEg2opSC7IC7SAjsuWEinP0AJjEC0TnTpHFzlvMMZSKniFzikQgYF3C7S-9at1u_STC9nHYMbG7kqcXEneNqaed9nnJg6NjWNMzpY9YYJ1qUlu68yYmxC3bmwmt_SmxPQbNqH4Mk9xTo2fpjn4snuNXg6Vdm8e90v08-uXH9e37d33m2_Xn-_anmMo7dAJxyxw7OhSMjb0CvdCmoEJ1hvMbE-Zco7AQEhv3dANhgDugS0pBguqo5fo06Hu_dxXT9aFksyo75OfTNrpaLz-9yb4tV7FrRaYU6pULfDhsUCKv2aXi558tm4cTXBxzpoQRgiva4--f4Zuasv107KmIDhWHZH8FEWoIByYwlCpd3_7Php-GlUFyAGwKeac3HBEAOt9HvQhD3qfB33IQxXJZyLriyl10rV3P56WtgdpP23-76mrP_yxwxOCB_-o260
CitedBy_id crossref_primary_10_1038_s41385_021_00467_7
crossref_primary_10_1007_s00262_020_02540_9
crossref_primary_10_5306_wjco_v12_i4_238
crossref_primary_10_1038_s41421_023_00605_4
crossref_primary_10_31083_j_fbl2903098
crossref_primary_10_3390_cancers13184708
crossref_primary_10_1002_cac2_12469
crossref_primary_10_3390_cancers12123705
crossref_primary_10_1053_j_gastro_2021_06_064
crossref_primary_10_3389_fimmu_2019_02534
crossref_primary_10_3390_cancers13030559
crossref_primary_10_1136_gutjnl_2020_322101
crossref_primary_10_1038_s41598_024_78908_z
crossref_primary_10_3389_fimmu_2022_1032314
crossref_primary_10_1038_s41467_024_51025_1
crossref_primary_10_3389_fonc_2020_01254
crossref_primary_10_3389_fonc_2021_819505
crossref_primary_10_1172_JCI137181
crossref_primary_10_1186_s13073_019_0662_6
crossref_primary_10_3389_fonc_2023_1067305
crossref_primary_10_1016_j_jtos_2022_04_008
crossref_primary_10_3389_fimmu_2022_1003626
crossref_primary_10_1038_s41588_022_01088_x
crossref_primary_10_1002_JLB_5MR0722_777R
crossref_primary_10_1007_s00259_023_06485_w
crossref_primary_10_1016_j_intimp_2025_114799
crossref_primary_10_1097_CJI_0000000000000357
crossref_primary_10_1038_s41423_022_00901_1
crossref_primary_10_1080_14760584_2023_2268724
crossref_primary_10_1136_jitc_2022_004638
crossref_primary_10_3390_ijms252010944
crossref_primary_10_1136_jitc_2022_004717
crossref_primary_10_3389_fimmu_2025_1578444
crossref_primary_10_1002_ctm2_253
crossref_primary_10_1016_j_canlet_2021_12_022
crossref_primary_10_1111_imr_12925
crossref_primary_10_3390_cancers14092241
crossref_primary_10_3390_cancers12113440
crossref_primary_10_1016_j_critrevonc_2025_104931
crossref_primary_10_1016_j_mam_2021_100967
crossref_primary_10_1080_21645515_2021_2024416
crossref_primary_10_1155_2022_9157455
crossref_primary_10_3390_ijms23010124
crossref_primary_10_1016_j_it_2022_04_010
crossref_primary_10_1002_jbm_a_37359
crossref_primary_10_1111_1751_2980_70001
crossref_primary_10_1016_j_isci_2024_110754
crossref_primary_10_1136_gutjnl_2020_320908
crossref_primary_10_3389_fimmu_2019_03080
crossref_primary_10_1038_s41590_023_01429_w
crossref_primary_10_1186_s12957_023_03009_6
crossref_primary_10_3389_fimmu_2023_1098847
crossref_primary_10_1126_sciimmunol_abd3489
crossref_primary_10_3390_ijms23147859
crossref_primary_10_1111_imr_12916
crossref_primary_10_1002_eji_202149759
crossref_primary_10_1158_2326_6066_CIR_21_0137
crossref_primary_10_1158_2159_8290_CD_20_0987
crossref_primary_10_1055_a_1472_2730
crossref_primary_10_1002_ctm2_70175
crossref_primary_10_1016_j_bbamcr_2022_119266
crossref_primary_10_3390_cancers13215440
crossref_primary_10_1038_s43018_025_00948_9
crossref_primary_10_1177_03000605221109382
crossref_primary_10_1002_hed_27774
crossref_primary_10_3389_fimmu_2022_803097
crossref_primary_10_3390_jpm14010108
crossref_primary_10_3389_fimmu_2022_959705
crossref_primary_10_1016_j_smim_2022_101670
crossref_primary_10_3389_fimmu_2022_1011590
crossref_primary_10_1136_gutjnl_2022_327496
crossref_primary_10_4132_jptm_2020_05_15
crossref_primary_10_1002_cyto_a_24480
crossref_primary_10_3389_fimmu_2023_1119383
crossref_primary_10_3390_cells11071062
crossref_primary_10_1016_j_intimp_2023_110733
crossref_primary_10_1016_j_smim_2020_101415
crossref_primary_10_3389_fcell_2022_915654
crossref_primary_10_1016_j_intimp_2023_111381
crossref_primary_10_1186_s13045_024_01549_2
crossref_primary_10_3389_fimmu_2019_03111
crossref_primary_10_1111_imr_13319
crossref_primary_10_3390_vaccines10071033
crossref_primary_10_3389_fimmu_2020_01466
crossref_primary_10_1038_s41586_022_05593_1
crossref_primary_10_1097_CM9_0000000000002781
crossref_primary_10_1164_rccm_202303_0442OC
crossref_primary_10_3389_fimmu_2023_1171826
crossref_primary_10_3389_fimmu_2022_957436
Cites_doi 10.1016/j.cell.2017.04.016
10.1158/1078-0432.CCR-11-1997
10.1158/1078-0432.CCR-17-2257
10.1038/s41586-018-0130-2
10.1038/nbt.3973
10.1158/2326-6066.CIR-14-0239
10.1016/j.it.2012.02.010
10.1111/cgf.12893
10.1126/science.aan6733
10.1084/jem.178.2.597
10.1002/0471142956.cy1017s53
10.1002/cyto.a.23738
10.1016/1074-7613(95)90025-X
10.1038/nm.3967
10.1016/j.celrep.2014.09.045
10.1016/j.ccell.2015.06.012
10.1038/nature11252
10.1038/mi.2015.69
10.1200/PO.18.00321
10.1200/JCO.2017.35.15_suppl.3033
10.1158/1078-0432.CCR-18-1749
10.1016/j.immuni.2013.02.010
10.4049/jimmunol.1402711
10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U
10.1016/j.immuni.2016.11.005
10.1038/s41416-019-0421-x
10.1111/cgf.12878
10.1186/1471-2407-7-33
10.1186/s13059-015-0620-6
10.1038/s41591-018-0057-z
10.1016/j.cels.2017.12.001
10.1158/0008-5472.CAN-16-3167
10.1126/science.aaa1348
10.1002/cjp2.113
10.1126/science.1129139
10.1016/j.cell.2016.01.002
10.1158/0008-5472.CAN-05-0044
10.1038/16717
10.1038/nbt.4096
10.1093/biostatistics/kxj037
10.1038/ng.3818
10.1056/NEJMoa1003466
10.1038/s41467-018-05072-0
10.1038/labinvest.3700055
10.1084/jem.20171934
10.1016/j.cell.2017.05.035
10.3389/fimmu.2012.00258
10.1002/eji.201040959
10.1053/j.gastro.2018.08.030
10.1038/s41467-017-01689-9
10.1140/epjb/e2013-40829-0
10.1038/363558a0
10.1158/1078-0432.CCR-13-1877
10.1056/NEJMoa1200690
10.1021/ac901049w
10.1101/316034
10.1007/s10479-011-0841-3
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020
Copyright_xml – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020
DBID 9YT
ACMMV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
88I
8AF
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1136/gutjnl-2019-318672
DatabaseName BMJ Open Access Journals (Free internet resource, activated by CARLI)
BMJ Journals:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest Central Student
MEDLINE - Academic
MEDLINE

ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3288
EndPage 703
ExternalDocumentID PMC7063399
31270164
10_1136_gutjnl_2019_318672
gutjnl
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GrantInformation_xml – fundername: ZonMw
  funderid: http://dx.doi.org/10.13039/501100001826
– fundername: KWF Kankerbestrijding
  funderid: http://dx.doi.org/10.13039/501100004622
– fundername: American Association for Cancer Research
  funderid: http://dx.doi.org/10.13039/100000043
– fundername: Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  funderid: http://dx.doi.org/10.13039/501100003246
– fundername: H2020 Marie Skłodowska-Curie Actions
  funderid: http://dx.doi.org/10.13039/100010665
– fundername: ;
GroupedDBID ---
.55
.VT
08G
0R~
18M
29I
2WC
39C
4.4
40O
53G
5GY
5VS
7X7
7~S
88E
88I
8AF
8F7
8FE
8FH
8FI
8FJ
9YT
AAHLL
AAOJX
AAUVZ
AAWJN
AAYEP
ABAAH
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACMMV
ACOFX
ACTZY
ADBBV
ADFRT
ADUGQ
AENEX
AFKRA
AFWFF
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BLJBA
BOMFT
BPHCQ
BTHHO
BVXVI
C45
CCPQU
CS3
CXRWF
DU5
DWQXO
E3Z
EBS
EJD
F5P
FD8
FYUFA
GNUQQ
H13
HAJ
HCIFZ
HMCUK
HZ~
IAO
IH2
IOF
L7B
LK8
M1P
M2P
M7P
N9A
NXWIF
O9-
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
RHI
RMJ
RPM
RV8
TEORI
TR2
UKHRP
UYXKK
V24
VM9
VVN
WH7
X7M
YFH
YOC
YQY
ZY1
.GJ
354
3O-
8R4
8R5
AAKAS
ACOAB
ACQSR
ADCEG
ADZCM
AGQPQ
AI.
ASPBG
AVWKF
AZFZN
BTFSW
C1A
CAG
COF
DIK
FEDTE
GX1
HVGLF
HYE
IEA
IHR
INH
INR
ITC
J5H
KQ8
NTWIH
OK1
Q2X
R53
VH1
W8F
WOQ
ZGI
ZXP
AAYXX
ACQHZ
AERUA
AFFHD
CITATION
PHGZM
PJZUB
PPXIY
PQGLB
ADGHP
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-b601t-f47e5c160e3d855fb90b78af575ba05cb359ee21f22bcef4fa210b15d301c1943
IEDL.DBID BENPR
ISICitedReferencesCount 89
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000521111900011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0017-5749
1468-3288
IngestDate Tue Nov 04 01:59:56 EST 2025
Fri Sep 05 07:52:07 EDT 2025
Tue Oct 07 07:32:58 EDT 2025
Tue Oct 07 07:14:20 EDT 2025
Mon Jul 21 06:02:39 EDT 2025
Sat Nov 29 04:04:17 EST 2025
Tue Nov 18 21:28:23 EST 2025
Thu Apr 24 23:10:20 EDT 2025
Thu Apr 24 22:50:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords immune landscape
colorectal cancer
single-cell immunophenotyping
innate lymphoid cells
mass cytometry
tissue-resident memory T cells
Language English
License This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b601t-f47e5c160e3d855fb90b78af575ba05cb359ee21f22bcef4fa210b15d301c1943
Notes Original article
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-4966-7036
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7063399
PMID 31270164
PQID 2372615901
PQPubID 2041069
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7063399
proquest_miscellaneous_2252266669
proquest_journals_3176094286
proquest_journals_2372615901
pubmed_primary_31270164
crossref_primary_10_1136_gutjnl_2019_318672
crossref_citationtrail_10_1136_gutjnl_2019_318672
bmj_primary_10_1136_gutjnl_2019_318672
bmj_journals_10_1136_gutjnl_2019_318672
PublicationCentury 2000
PublicationDate 2020-04-01
PublicationDateYYYYMMDD 2020-04-01
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationSeriesTitle Original research
PublicationTitle Gut
PublicationTitleAbbrev Gut
PublicationTitleAlternate Gut
PublicationYear 2020
Publisher BMJ Publishing Group Ltd and British Society of Gastroenterology
BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: BMJ Publishing Group Ltd and British Society of Gastroenterology
– name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References van der Maaten, Hinton (R20) 2008; 9
Simoni, Becht, Fehlings (R23) 2018; 557
Kim, Song, Park (R55) 2018; 155
Rajagopalan, Long (R38) 2012; 3
Kelderman, Schumacher, Kvistborg (R4) 2015; 28
Angelova, Charoentong, Hackl (R27) 2015; 16
Duhen, Duhen, Montler (R22) 2018; 9
Ionov, Peinado, Malkhosyan (R6) 1993; 363
Höllt, Pezzotti, van Unen (R13) 2016; 35
Dierssen, de Miranda, Ferrone (R40) 2007; 7
Topalian, Hodi, Brahmer (R2) 2012; 366
Webb, Milne, Nelson (R45) 2015; 3
Johnson, Li, Rabinovic (R17) 2007; 8
Butler, Hoffman, Smibert (R18) 2018; 36
Abdelaal, van Unen, Höllt (R16) 2019
van Unen, Höllt, Pezzotti (R15) 2017; 8
Wagtmann, Biassoni, Cantoni (R37) 1995; 2
Menon, Janssen-van Rhijn, Morreau (R25) 2004; 84
Middha, Yaeger, Shia (R56) 2019; 3
Galon, Costes, Sanchez-Cabo (R26) 2006; 313
de Miranda, Goudkade, Jordanova (R9) 2012; 18
Chevrier, Levine, Zanotelli (R10) 2017; 169
Fergusson, Hühn, Swadling (R52) 2016; 9
Djenidi, Adam, Goubar (R46) 2015; 194
Burris, Callahan, Tolcher (R50) 2017; 35
Santegoets, van Ham, Ehsan (R48) 2019; 25
Li, van Unen, Höllt (R24) 2018; 215
Li, Courtois, Sengupta (R29) 2017; 49
(R7) 2012; 487
Dadi, Chhangawala, Whitlock (R34) 2016; 164
Guinney, Dienstmann, Wang (R28) 2015; 21
Fergusson, Smith, Fleming (R51) 2014; 9
Edwards, Wilmott, Madore (R47) 2018; 24
Bendall, Nolan, Roederer (R33) 2012; 33
Simoni, Fehlings, Kløverpris (R36) 2017; 46
Kansy, Concha-Benavente, Srivastava (R54) 2017; 77
Hodi, O’Day, McDermott (R1) 2010; 363
Moretta, Vitale, Bottino (R39) 1993; 178
Zheng, Zheng, Yoo (R11) 2017; 169
Smyrk, Watson, Kaul (R8) 2001; 91
Schulz, Zanotelli, Fischer (R31) 2018; 6
Thommen, Koelzer, Herzig (R53) 2018; 24
Hutloff, Dittrich, Beier (R49) 1999; 397
Pezzotti, Höllt, Lelieveldt (R14) 2016; 35
Kloor, Becker, Benner (R41) 2005; 65
Peterson, Zhang, Kumar (R30) 2017; 35
Iwasaki, Tanaka, Kobayashi (R43) 2011; 41
Kotecha, Krutzik, Irish (R12) 2010; Chapter 10
Fuchs, Vermi, Lee (R35) 2013; 38
Rizvi, Hellmann, Snyder (R3) 2015; 348
Ijsselsteijn, Petitprez, Lacroix (R42) 2019; 120
Webb, Milne, Watson (R44) 2014; 20
Ijsselsteijn, Brouwer, Abdulrahman (R21) 2019; 5
Waltman, van Eck (R19) 2013; 86
Bandura, Baranov, Ornatsky (R32) 2009; 81
Le, Durham, Smith (R5) 2017; 357
Webb, Milne, Watson 2014; 20
Bendall, Nolan, Roederer 2012; 33
Kelderman, Schumacher, Kvistborg 2015; 28
2012; 487
Rajagopalan, Long 2012; 3
Fuchs, Vermi, Lee 2013; 38
Kansy, Concha-Benavente, Srivastava 2017; 77
Simoni, Fehlings, Kløverpris 2017; 46
Djenidi, Adam, Goubar 2015; 194
Zheng, Zheng, Yoo 2017; 169
Moretta, Vitale, Bottino 1993; 178
Kotecha, Krutzik, Irish 2010; Chapter 10
Dierssen, de Miranda, Ferrone 2007; 7
Edwards, Wilmott, Madore 2018; 24
Iwasaki, Tanaka, Kobayashi 2011; 41
Menon, Janssen-van Rhijn, Morreau 2004; 84
Dadi, Chhangawala, Whitlock 2016; 164
Fergusson, Smith, Fleming 2014; 9
Höllt, Pezzotti, van Unen 2016; 35
Hutloff, Dittrich, Beier 1999; 397
Thommen, Koelzer, Herzig 2018; 24
Simoni, Becht, Fehlings 2018; 557
Smyrk, Watson, Kaul 2001; 91
Li, van Unen, Höllt 2018; 215
Peterson, Zhang, Kumar 2017; 35
Kloor, Becker, Benner 2005; 65
Galon, Costes, Sanchez-Cabo 2006; 313
Bandura, Baranov, Ornatsky 2009; 81
Abdelaal, van Unen, Höllt 2019
Guinney, Dienstmann, Wang 2015; 21
Topalian, Hodi, Brahmer 2012; 366
Ionov, Peinado, Malkhosyan 1993; 363
Ijsselsteijn, Petitprez, Lacroix 2019; 120
Schulz, Zanotelli, Fischer 2018; 6
van Unen, Höllt, Pezzotti 2017; 8
Johnson, Li, Rabinovic 2007; 8
Wagtmann, Biassoni, Cantoni 1995; 2
Ijsselsteijn, Brouwer, Abdulrahman 2019; 5
Li, Courtois, Sengupta 2017; 49
Webb, Milne, Nelson 2015; 3
Rizvi, Hellmann, Snyder 2015; 348
Fergusson, Hühn, Swadling 2016; 9
Duhen, Duhen, Montler 2018; 9
Santegoets, van Ham, Ehsan 2019; 25
Kim, Song, Park 2018; 155
Waltman, van Eck 2013; 86
Chevrier, Levine, Zanotelli 2017; 169
Pezzotti, Höllt, Lelieveldt 2016; 35
Middha, Yaeger, Shia 2019; 3
de Miranda, Goudkade, Jordanova 2012; 18
Hodi, O’Day, McDermott 2010; 363
Butler, Hoffman, Smibert 2018; 36
Burris, Callahan, Tolcher 2017; 35
van der Maaten, Hinton 2008; 9
Angelova, Charoentong, Hackl 2015; 16
Le, Durham, Smith 2017; 357
2024111023102747000_69.4.691.43
2024111023102747000_69.4.691.44
2024111023102747000_69.4.691.41
2024111023102747000_69.4.691.42
Middha (2024111023102747000_69.4.691.56) 2019; 3
2024111023102747000_69.4.691.49
2024111023102747000_69.4.691.47
2024111023102747000_69.4.691.48
2024111023102747000_69.4.691.45
2024111023102747000_69.4.691.46
2024111023102747000_69.4.691.10
2024111023102747000_69.4.691.54
2024111023102747000_69.4.691.11
2024111023102747000_69.4.691.55
2024111023102747000_69.4.691.52
2024111023102747000_69.4.691.53
2024111023102747000_69.4.691.50
2024111023102747000_69.4.691.51
2024111023102747000_69.4.691.18
Dierssen (2024111023102747000_69.4.691.40) 2007; 7
2024111023102747000_69.4.691.19
2024111023102747000_69.4.691.16
2024111023102747000_69.4.691.17
2024111023102747000_69.4.691.14
2024111023102747000_69.4.691.15
2024111023102747000_69.4.691.13
2024111023102747000_69.4.691.21
2024111023102747000_69.4.691.22
2024111023102747000_69.4.691.20
Kotecha (2024111023102747000_69.4.691.12) 2010; Chapter 10
2024111023102747000_69.4.691.1
2024111023102747000_69.4.691.2
2024111023102747000_69.4.691.3
2024111023102747000_69.4.691.4
2024111023102747000_69.4.691.5
2024111023102747000_69.4.691.6
2024111023102747000_69.4.691.7
2024111023102747000_69.4.691.29
2024111023102747000_69.4.691.8
2024111023102747000_69.4.691.9
2024111023102747000_69.4.691.27
2024111023102747000_69.4.691.28
2024111023102747000_69.4.691.25
2024111023102747000_69.4.691.26
2024111023102747000_69.4.691.23
2024111023102747000_69.4.691.24
2024111023102747000_69.4.691.32
2024111023102747000_69.4.691.33
2024111023102747000_69.4.691.30
2024111023102747000_69.4.691.31
2024111023102747000_69.4.691.38
2024111023102747000_69.4.691.39
2024111023102747000_69.4.691.36
2024111023102747000_69.4.691.37
2024111023102747000_69.4.691.34
2024111023102747000_69.4.691.35
32139551 - Gut. 2020 Dec;69(12):2261-2263
References_xml – volume: 169
  start-page: 736
  year: 2017
  ident: R10
  article-title: An Immune Atlas of Clear Cell Renal Cell Carcinoma
  publication-title: Cell
  doi: 10.1016/j.cell.2017.04.016
– volume: 18
  start-page: 1237
  year: 2012
  ident: R9
  article-title: Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-11-1997
– volume: 24
  start-page: 3036
  year: 2018
  ident: R47
  article-title: CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-2257
– volume: 557
  start-page: 575
  year: 2018
  ident: R23
  article-title: Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
  publication-title: Nature
  doi: 10.1038/s41586-018-0130-2
– volume: 35
  start-page: 936
  year: 2017
  ident: R30
  article-title: Multiplexed quantification of proteins and transcripts in single cells
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.3973
– volume: 3
  start-page: 926
  year: 2015
  ident: R45
  article-title: PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-14-0239
– volume: 33
  start-page: 323
  year: 2012
  ident: R33
  article-title: A deep profiler’s guide to cytometry
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2012.02.010
– volume: 35
  start-page: 171
  year: 2016
  ident: R13
  article-title: Cytosplore: Interactive Immune Cell Phenotyping for Large Single-Cell Datasets
  publication-title: Computer Graphics Forum
  doi: 10.1111/cgf.12893
– volume: 357
  start-page: 409
  year: 2017
  ident: R5
  article-title: Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
  publication-title: Science
  doi: 10.1126/science.aan6733
– volume: 178
  start-page: 597
  year: 1993
  ident: R39
  article-title: P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities
  publication-title: J Exp Med
  doi: 10.1084/jem.178.2.597
– volume: Chapter 10
  start-page: 10.17.1
  year: 2010
  ident: R12
  article-title: Web-based analysis and publication of flow cytometry experiments
  publication-title: Curr Protoc Cytom
  doi: 10.1002/0471142956.cy1017s53
– year: 2019
  ident: R16
  article-title: Predicting cell populations in single cell mass cytometry data
  publication-title: Cytometry A
  doi: 10.1002/cyto.a.23738
– volume: 2
  start-page: 439
  year: 1995
  ident: R37
  article-title: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
  publication-title: Immunity
  doi: 10.1016/1074-7613(95)90025-X
– volume: 9
  start-page: 2579
  year: 2008
  ident: R20
  article-title: Visualizing high-dimensional data using t-SNE
  publication-title: J Mach Learn Res
– volume: 21
  start-page: 1350
  year: 2015
  ident: R28
  article-title: The consensus molecular subtypes of colorectal cancer
  publication-title: Nat Med
  doi: 10.1038/nm.3967
– volume: 9
  start-page: 1075
  year: 2014
  ident: R51
  article-title: CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.09.045
– volume: 28
  start-page: 11
  year: 2015
  ident: R4
  article-title: Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.06.012
– volume: 487
  start-page: 330
  year: 2012
  ident: R7
  article-title: Comprehensive molecular characterization of human colon and rectal cancer
  publication-title: Nature
  doi: 10.1038/nature11252
– volume: 9
  start-page: 401
  year: 2016
  ident: R52
  article-title: CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut
  publication-title: Mucosal Immunol
  doi: 10.1038/mi.2015.69
– volume: 3
  start-page: 1
  year: 2019
  ident: R56
  article-title: Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High
  publication-title: JCO Precis Oncol
  doi: 10.1200/PO.18.00321
– volume: 35
  start-page: 3033
  issue: 15_suppl
  year: 2017
  ident: R50
  article-title: Phase 1 safety of ICOS agonist antibody JTX-2011 alone and with nivolumab (nivo) in advanced solid tumors; predicted vs observed pharmacokinetics (PK) in ICONIC
  publication-title: Journal of Clinical Oncology
  doi: 10.1200/JCO.2017.35.15_suppl.3033
– volume: 25
  start-page: 240
  year: 2019
  ident: R48
  article-title: The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-1749
– volume: 38
  start-page: 769
  year: 2013
  ident: R35
  article-title: Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.02.010
– volume: 194
  start-page: 3475
  year: 2015
  ident: R46
  article-title: CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1402711
– volume: 91
  start-page: 2417
  year: 2001
  ident: R8
  article-title: Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
  publication-title: Cancer
  doi: 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U
– volume: 46
  start-page: 148
  year: 2017
  ident: R36
  article-title: Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.11.005
– volume: 120
  start-page: 815
  year: 2019
  ident: R42
  article-title: Revisiting immune escape in colorectal cancer in the era of immunotherapy
  publication-title: Br J Cancer
  doi: 10.1038/s41416-019-0421-x
– volume: 35
  start-page: 21
  year: 2016
  ident: R14
  article-title: Hierarchical Stochastic Neighbor Embedding
  publication-title: Computer Graphics Forum
  doi: 10.1111/cgf.12878
– volume: 7
  year: 2007
  ident: R40
  article-title: HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-7-33
– volume: 16
  start-page: 64
  year: 2015
  ident: R27
  article-title: Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
  publication-title: Genome Biol
  doi: 10.1186/s13059-015-0620-6
– volume: 24
  start-page: 994
  year: 2018
  ident: R53
  article-title: A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0057-z
– volume: 6
  start-page: 25
  year: 2018
  ident: R31
  article-title: Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry
  publication-title: Cell Syst
  doi: 10.1016/j.cels.2017.12.001
– volume: 77
  start-page: 6353
  year: 2017
  ident: R54
  article-title: PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-3167
– volume: 348
  start-page: 124
  year: 2015
  ident: R3
  article-title: Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
  publication-title: Science
  doi: 10.1126/science.aaa1348
– volume: 5
  start-page: 3
  year: 2019
  ident: R21
  article-title: Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification
  publication-title: J Pathol Clin Res
  doi: 10.1002/cjp2.113
– volume: 313
  start-page: 1960
  year: 2006
  ident: R26
  article-title: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
  publication-title: Science
  doi: 10.1126/science.1129139
– volume: 164
  start-page: 365
  year: 2016
  ident: R34
  article-title: Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
  publication-title: Cell
  doi: 10.1016/j.cell.2016.01.002
– volume: 65
  start-page: 6418
  year: 2005
  ident: R41
  article-title: Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-0044
– volume: 397
  start-page: 263
  year: 1999
  ident: R49
  article-title: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
  publication-title: Nature
  doi: 10.1038/16717
– volume: 36
  start-page: 411
  year: 2018
  ident: R18
  article-title: Integrating single-cell transcriptomic data across different conditions, technologies, and species
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.4096
– volume: 8
  start-page: 118
  year: 2007
  ident: R17
  article-title: Adjusting batch effects in microarray expression data using empirical Bayes methods
  publication-title: Biostatistics
  doi: 10.1093/biostatistics/kxj037
– volume: 49
  start-page: 708
  year: 2017
  ident: R29
  article-title: Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
  publication-title: Nat Genet
  doi: 10.1038/ng.3818
– volume: 363
  start-page: 711
  year: 2010
  ident: R1
  article-title: Improved survival with ipilimumab in patients with metastatic melanoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1003466
– volume: 9
  start-page: 2724
  year: 2018
  ident: R22
  article-title: Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-05072-0
– volume: 84
  start-page: 493
  year: 2004
  ident: R25
  article-title: Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
  publication-title: Lab Invest
  doi: 10.1038/labinvest.3700055
– volume: 215
  start-page: 1383
  year: 2018
  ident: R24
  article-title: Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine
  publication-title: J Exp Med
  doi: 10.1084/jem.20171934
– volume: 169
  start-page: 1342
  year: 2017
  ident: R11
  article-title: Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.035
– volume: 3
  start-page: 258
  year: 2012
  ident: R38
  article-title: KIR2DL4 (CD158d): An activation receptor for HLA-G
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2012.00258
– volume: 41
  start-page: 345
  year: 2011
  ident: R43
  article-title: Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201040959
– volume: 155
  start-page: 1936
  year: 2018
  ident: R55
  article-title: Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2018.08.030
– volume: 8
  start-page: 1740
  year: 2017
  ident: R15
  article-title: Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01689-9
– volume: 86
  start-page: 471
  year: 2013
  ident: R19
  article-title: A smart local moving algorithm for large-scale modularity-based community detection
  publication-title: Eur Phys J B
  doi: 10.1140/epjb/e2013-40829-0
– volume: 363
  start-page: 558
  year: 1993
  ident: R6
  article-title: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
  publication-title: Nature
  doi: 10.1038/363558a0
– volume: 20
  start-page: 434
  year: 2014
  ident: R44
  article-title: Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-13-1877
– volume: 366
  start-page: 2443
  year: 2012
  ident: R2
  article-title: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1200690
– volume: 81
  start-page: 6813
  year: 2009
  ident: R32
  article-title: Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry
  publication-title: Anal Chem
  doi: 10.1021/ac901049w
– volume: 363
  start-page: 711
  year: 2010
  article-title: Improved survival with ipilimumab in patients with metastatic melanoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1003466
– volume: 164
  start-page: 365
  year: 2016
  article-title: Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
  publication-title: Cell
  doi: 10.1016/j.cell.2016.01.002
– year: 2019
  article-title: Predicting cell populations in single cell mass cytometry data
  publication-title: Cytometry A
  doi: 10.1002/cyto.a.23738
– volume: 33
  start-page: 323
  year: 2012
  article-title: A deep profiler’s guide to cytometry
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2012.02.010
– volume: 155
  start-page: 1936
  year: 2018
  article-title: Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2018.08.030
– volume: 169
  start-page: 736
  year: 2017
  article-title: An Immune Atlas of Clear Cell Renal Cell Carcinoma
  publication-title: Cell
  doi: 10.1016/j.cell.2017.04.016
– volume: 35
  start-page: 171
  year: 2016
  article-title: Cytosplore: Interactive Immune Cell Phenotyping for Large Single-Cell Datasets
  publication-title: Computer Graphics Forum
  doi: 10.1111/cgf.12893
– volume: 25
  start-page: 240
  year: 2019
  article-title: The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-1749
– volume: 86
  start-page: 471
  year: 2013
  article-title: A smart local moving algorithm for large-scale modularity-based community detection
  publication-title: Eur Phys J B
  doi: 10.1140/epjb/e2013-40829-0
– volume: 194
  start-page: 3475
  year: 2015
  article-title: CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1402711
– volume: 28
  start-page: 11
  year: 2015
  article-title: Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.06.012
– volume: 3
  start-page: 1
  year: 2019
  article-title: Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High
  publication-title: JCO Precis Oncol
  doi: 10.1200/PO.18.00321
– volume: 21
  start-page: 1350
  year: 2015
  article-title: The consensus molecular subtypes of colorectal cancer
  publication-title: Nat Med
  doi: 10.1038/nm.3967
– volume: 35
  start-page: 936
  year: 2017
  article-title: Multiplexed quantification of proteins and transcripts in single cells
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.3973
– volume: 9
  start-page: 1075
  year: 2014
  article-title: CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.09.045
– volume: 65
  start-page: 6418
  year: 2005
  article-title: Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-0044
– volume: 5
  start-page: 3
  year: 2019
  article-title: Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification
  publication-title: J Pathol Clin Res
  doi: 10.1002/cjp2.113
– volume: 46
  start-page: 148
  year: 2017
  article-title: Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.11.005
– volume: 77
  start-page: 6353
  year: 2017
  article-title: PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-3167
– volume: 2
  start-page: 439
  year: 1995
  article-title: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
  publication-title: Immunity
  doi: 10.1016/1074-7613(95)90025-X
– volume: 366
  start-page: 2443
  year: 2012
  article-title: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1200690
– volume: 91
  start-page: 2417
  year: 2001
  article-title: Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
  publication-title: Cancer
  doi: 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U
– volume: 357
  start-page: 409
  year: 2017
  article-title: Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
  publication-title: Science
  doi: 10.1126/science.aan6733
– volume: 81
  start-page: 6813
  year: 2009
  article-title: Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry
  publication-title: Anal Chem
  doi: 10.1021/ac901049w
– volume: 35
  start-page: 3033
  issue: 15_suppl
  year: 2017
  article-title: Phase 1 safety of ICOS agonist antibody JTX-2011 alone and with nivolumab (nivo) in advanced solid tumors; predicted vs observed pharmacokinetics (PK) in ICONIC
  publication-title: Journal of Clinical Oncology
  doi: 10.1200/JCO.2017.35.15_suppl.3033
– volume: 8
  start-page: 118
  year: 2007
  article-title: Adjusting batch effects in microarray expression data using empirical Bayes methods
  publication-title: Biostatistics
  doi: 10.1093/biostatistics/kxj037
– volume: 38
  start-page: 769
  year: 2013
  article-title: Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.02.010
– volume: 363
  start-page: 558
  year: 1993
  article-title: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
  publication-title: Nature
  doi: 10.1038/363558a0
– volume: 348
  start-page: 124
  year: 2015
  article-title: Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
  publication-title: Science
  doi: 10.1126/science.aaa1348
– volume: 557
  start-page: 575
  year: 2018
  article-title: Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
  publication-title: Nature
  doi: 10.1038/s41586-018-0130-2
– volume: 178
  start-page: 597
  year: 1993
  article-title: P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities
  publication-title: J Exp Med
  doi: 10.1084/jem.178.2.597
– volume: 9
  start-page: 2579
  year: 2008
  article-title: Visualizing high-dimensional data using t-SNE
  publication-title: J Mach Learn Res
– volume: 84
  start-page: 493
  year: 2004
  article-title: Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
  publication-title: Lab Invest
  doi: 10.1038/labinvest.3700055
– volume: 6
  start-page: 25
  year: 2018
  article-title: Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry
  publication-title: Cell Syst
  doi: 10.1016/j.cels.2017.12.001
– volume: 7
  year: 2007
  article-title: HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-7-33
– volume: Chapter 10
  start-page: 10.17.1
  year: 2010
  article-title: Web-based analysis and publication of flow cytometry experiments
  publication-title: Curr Protoc Cytom
  doi: 10.1002/0471142956.cy1017s53
– volume: 36
  start-page: 411
  year: 2018
  article-title: Integrating single-cell transcriptomic data across different conditions, technologies, and species
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.4096
– volume: 24
  start-page: 994
  year: 2018
  article-title: A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0057-z
– volume: 487
  start-page: 330
  year: 2012
  article-title: Comprehensive molecular characterization of human colon and rectal cancer
  publication-title: Nature
  doi: 10.1038/nature11252
– volume: 24
  start-page: 3036
  year: 2018
  article-title: CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-2257
– volume: 49
  start-page: 708
  year: 2017
  article-title: Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
  publication-title: Nat Genet
  doi: 10.1038/ng.3818
– volume: 215
  start-page: 1383
  year: 2018
  article-title: Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine
  publication-title: J Exp Med
  doi: 10.1084/jem.20171934
– volume: 18
  start-page: 1237
  year: 2012
  article-title: Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-11-1997
– volume: 9
  start-page: 2724
  year: 2018
  article-title: Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-05072-0
– volume: 35
  start-page: 21
  year: 2016
  article-title: Hierarchical Stochastic Neighbor Embedding
  publication-title: Computer Graphics Forum
  doi: 10.1111/cgf.12878
– volume: 169
  start-page: 1342
  year: 2017
  article-title: Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.035
– volume: 8
  start-page: 1740
  year: 2017
  article-title: Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01689-9
– volume: 20
  start-page: 434
  year: 2014
  article-title: Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-13-1877
– volume: 41
  start-page: 345
  year: 2011
  article-title: Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201040959
– volume: 9
  start-page: 401
  year: 2016
  article-title: CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut
  publication-title: Mucosal Immunol
  doi: 10.1038/mi.2015.69
– volume: 16
  start-page: 64
  year: 2015
  article-title: Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
  publication-title: Genome Biol
  doi: 10.1186/s13059-015-0620-6
– volume: 313
  start-page: 1960
  year: 2006
  article-title: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
  publication-title: Science
  doi: 10.1126/science.1129139
– volume: 3
  start-page: 258
  year: 2012
  article-title: KIR2DL4 (CD158d): An activation receptor for HLA-G
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2012.00258
– volume: 120
  start-page: 815
  year: 2019
  article-title: Revisiting immune escape in colorectal cancer in the era of immunotherapy
  publication-title: Br J Cancer
  doi: 10.1038/s41416-019-0421-x
– volume: 3
  start-page: 926
  year: 2015
  article-title: PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-14-0239
– volume: 397
  start-page: 263
  year: 1999
  article-title: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
  publication-title: Nature
  doi: 10.1038/16717
– ident: 2024111023102747000_69.4.691.34
  doi: 10.1016/j.cell.2016.01.002
– ident: 2024111023102747000_69.4.691.46
  doi: 10.4049/jimmunol.1402711
– ident: 2024111023102747000_69.4.691.48
  doi: 10.1158/1078-0432.CCR-18-1749
– ident: 2024111023102747000_69.4.691.49
  doi: 10.1038/16717
– ident: 2024111023102747000_69.4.691.43
  doi: 10.1002/eji.201040959
– ident: 2024111023102747000_69.4.691.47
  doi: 10.1158/1078-0432.CCR-17-2257
– ident: 2024111023102747000_69.4.691.16
  doi: 10.1101/316034
– ident: 2024111023102747000_69.4.691.4
  doi: 10.1016/j.ccell.2015.06.012
– ident: 2024111023102747000_69.4.691.18
  doi: 10.1038/nbt.4096
– ident: 2024111023102747000_69.4.691.50
  doi: 10.1200/JCO.2017.35.15_suppl.3033
– ident: 2024111023102747000_69.4.691.27
  doi: 10.1186/s13059-015-0620-6
– ident: 2024111023102747000_69.4.691.22
  doi: 10.1038/s41467-018-05072-0
– volume: 7
  year: 2007
  ident: 2024111023102747000_69.4.691.40
  article-title: HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-7-33
– ident: 2024111023102747000_69.4.691.25
  doi: 10.1038/labinvest.3700055
– ident: 2024111023102747000_69.4.691.51
  doi: 10.1016/j.celrep.2014.09.045
– volume: Chapter 10
  start-page: 10.17.1
  year: 2010
  ident: 2024111023102747000_69.4.691.12
  article-title: Web-based analysis and publication of flow cytometry experiments
  publication-title: Curr Protoc Cytom
– ident: 2024111023102747000_69.4.691.33
  doi: 10.1016/j.it.2012.02.010
– ident: 2024111023102747000_69.4.691.38
  doi: 10.3389/fimmu.2012.00258
– ident: 2024111023102747000_69.4.691.44
  doi: 10.1158/1078-0432.CCR-13-1877
– ident: 2024111023102747000_69.4.691.54
  doi: 10.1158/0008-5472.CAN-16-3167
– ident: 2024111023102747000_69.4.691.7
  doi: 10.1038/nature11252
– ident: 2024111023102747000_69.4.691.42
  doi: 10.1038/s41416-019-0421-x
– ident: 2024111023102747000_69.4.691.30
  doi: 10.1038/nbt.3973
– ident: 2024111023102747000_69.4.691.15
  doi: 10.1038/s41467-017-01689-9
– ident: 2024111023102747000_69.4.691.1
  doi: 10.1056/NEJMoa1003466
– ident: 2024111023102747000_69.4.691.9
  doi: 10.1158/1078-0432.CCR-11-1997
– ident: 2024111023102747000_69.4.691.37
  doi: 10.1016/1074-7613(95)90025-X
– ident: 2024111023102747000_69.4.691.8
  doi: 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U
– ident: 2024111023102747000_69.4.691.13
  doi: 10.1111/cgf.12893
– ident: 2024111023102747000_69.4.691.6
  doi: 10.1038/363558a0
– ident: 2024111023102747000_69.4.691.10
  doi: 10.1016/j.cell.2017.04.016
– ident: 2024111023102747000_69.4.691.53
  doi: 10.1038/s41591-018-0057-z
– ident: 2024111023102747000_69.4.691.3
  doi: 10.1126/science.aaa1348
– ident: 2024111023102747000_69.4.691.31
  doi: 10.1016/j.cels.2017.12.001
– ident: 2024111023102747000_69.4.691.14
  doi: 10.1111/cgf.12878
– ident: 2024111023102747000_69.4.691.23
  doi: 10.1038/s41586-018-0130-2
– ident: 2024111023102747000_69.4.691.20
  doi: 10.1007/s10479-011-0841-3
– ident: 2024111023102747000_69.4.691.39
  doi: 10.1084/jem.178.2.597
– volume: 3
  start-page: 1
  year: 2019
  ident: 2024111023102747000_69.4.691.56
  article-title: Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High
  publication-title: JCO Precis Oncol
  doi: 10.1200/PO.18.00321
– ident: 2024111023102747000_69.4.691.19
  doi: 10.1140/epjb/e2013-40829-0
– ident: 2024111023102747000_69.4.691.45
  doi: 10.1158/2326-6066.CIR-14-0239
– ident: 2024111023102747000_69.4.691.36
  doi: 10.1016/j.immuni.2016.11.005
– ident: 2024111023102747000_69.4.691.17
  doi: 10.1093/biostatistics/kxj037
– ident: 2024111023102747000_69.4.691.2
  doi: 10.1056/NEJMoa1200690
– ident: 2024111023102747000_69.4.691.32
  doi: 10.1021/ac901049w
– ident: 2024111023102747000_69.4.691.21
  doi: 10.1002/cjp2.113
– ident: 2024111023102747000_69.4.691.35
  doi: 10.1016/j.immuni.2013.02.010
– ident: 2024111023102747000_69.4.691.24
  doi: 10.1084/jem.20171934
– ident: 2024111023102747000_69.4.691.28
  doi: 10.1038/nm.3967
– ident: 2024111023102747000_69.4.691.29
  doi: 10.1038/ng.3818
– ident: 2024111023102747000_69.4.691.5
  doi: 10.1126/science.aan6733
– ident: 2024111023102747000_69.4.691.52
  doi: 10.1038/mi.2015.69
– ident: 2024111023102747000_69.4.691.26
  doi: 10.1126/science.1129139
– ident: 2024111023102747000_69.4.691.11
  doi: 10.1016/j.cell.2017.05.035
– ident: 2024111023102747000_69.4.691.41
  doi: 10.1158/0008-5472.CAN-05-0044
– ident: 2024111023102747000_69.4.691.55
  doi: 10.1053/j.gastro.2018.08.030
– reference: 32139551 - Gut. 2020 Dec;69(12):2261-2263
SSID ssj0008891
Score 2.59787
Snippet ObjectiveA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We...
A comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled...
SourceID pubmedcentral
proquest
pubmed
crossref
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 691
SubjectTerms Antibodies
Antigens, CD - metabolism
Cancer
Cancer immunotherapy
Cancer therapies
Case-Control Studies
CD103 antigen
CD38 antigen
CD56 antigen
CD69 antigen
CD7 antigen
CD8 Antigens - metabolism
Cells
Clustering
Colon
Colonic Neoplasms - immunology
Colonic Neoplasms - metabolism
Colonic Neoplasms - pathology
Colorectal cancer
Colorectal carcinoma
Cytotoxicity
Flow Cytometry
Genomics
GI cancer
Histocompatibility antigen HLA
Humans
immune landscape
Immunity
Immunofluorescence
Immunogenicity
Immunoglobulins
Immunotherapy
innate lymphoid cells
Integrin alpha Chains - metabolism
Lymph nodes
Lymphatic system
Lymphocyte Count
Lymphocytes
Lymphocytes T
Lymphocytes, Tumor-Infiltrating
mass cytometry
Medical research
Metastases
Mismatch repair
Mucosa
Mutation
Patients
PD-1 protein
Peripheral blood
Phenotypes
Principal components analysis
Ribonucleic acid
RNA
single-cell immunophenotyping
tissue-resident memory T cells
Transcription
Tumors
Title High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity
URI https://gut.bmj.com/content/early/2019/07/03/gutjnl-2019-318672.full
https://gut.bmj.com/content/69/4/691.full
https://www.ncbi.nlm.nih.gov/pubmed/31270164
https://www.proquest.com/docview/2372615901
https://www.proquest.com/docview/3176094286
https://www.proquest.com/docview/2252266669
https://pubmed.ncbi.nlm.nih.gov/PMC7063399
Volume 69
WOSCitedRecordID wos000521111900011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1468-3288
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0008891
  issn: 0017-5749
  databaseCode: M7P
  dateStart: 19600301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest - Health & Medical Complete保健、医学与药学数据库
  customDbUrl:
  eissn: 1468-3288
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0008891
  issn: 0017-5749
  databaseCode: 7X7
  dateStart: 19600301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1468-3288
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0008891
  issn: 0017-5749
  databaseCode: BENPR
  dateStart: 19600301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (subscription)
  customDbUrl:
  eissn: 1468-3288
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0008891
  issn: 0017-5749
  databaseCode: M2P
  dateStart: 19600301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED7RDiFe-A0rjMlICB5QtMaJY_sJAdrEA6sqBFLfothxWKc22dp00v577hIno4AqJPoQqbITu73z5Tv77juA19xmibCZCxDbZkFscrSDMteB0lJYK4RKTCPpL3IyUbOZnvoNt7UPq-xsYmOo88rSHvkRjySCfcqUfH9xGVDVKDpd9SU0BrBHTGXxEPY-Hk-mX3tbrLqaeWiLhYx1lzYTJUc_NvV5uUAtCTWlECfEETwwy_PtF9QfqPP34Mlf3kYn9__3dzyAex6Hsg-t4jyEW658BHdO_Un7YzijAJAgJ-7_lreD2eu6WlL9Lcsyz2TCqoIR6zVZTepBGrRiRAqFSs3K6sotWJOaQiV9qHNGScGbJQ7O5k1iSn39BL6fHH_79DnwVRkCg85bHRSxdMKGydhFuRKiMHpspMoKxH0mGwtrIqGd42HBubGuiIsMvUoTihxNiUUZRU9hWFal2weG7opWiPGkIm71PDeJ42OrcBgV4UP1CN6iQFK_qtZp47BESdqKLiXRpa3oRvCGel60DB07O4addFPrWdCpGMdi5z3v-nv-ZYSDTvA3M7-R-l-bEcQl6GdzlYzgVd-MC51Ob7LSVRt8BCeojB_8W561KtjPJqL4AXR8RyC3lLPvQCTi2y3l_KwhE5eIURGkPt896xdwl9NGQxOydADDerVxL-G2varn69UhDORMNld16FcgfjvlU7rK6U_zFDm3
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61BQEX3o9AgUXicUBW7XXW6z0ghICqVdOIQ5FyM7vrNU2V2CVxivKn-I3M-FUCKOLSA7nueHdjz8zOZ898A_CcWx0Jq52Hsa32-iZFPyhT5cVKCmuFiCNTPemBHA7j0Uh92oAfbS0MpVW2PrFy1Glh6R35Dg8lBvtUKfn29JtHXaPo62rbQqNWiwO3_I6Qbf5m_wM-3xec7348er_nNV0FPIPgo_SyvnTCBpHvwjQWIjPKNzLWGcYtRvvCmlAo53iQcW6sy_qZRlRkApGiKViE_CHOuwmX0I9LSiGTow7gUcZQ0Hp-IfuqLdIJo52vi_Ikn6BOBooKliNiJN4005PV4_CPGPf3VM1fzr7dG__bXbsJ15som72rzeIWbLj8Nlw5bPII7sAxpbd4KXU2qFlJmF2WxZS6i1mmG54WVmSMOL3pTCAJso8ZI8orNFmWF2duwqrCG2pYRMKaSp4XU1ycjauym3J5Fz5fyP-8B1t5kbsHwBCMqRgjWBkTc3yamshx38a4TBzipKoHr1ABksZnzJMKjoVRUqtKQqqS1KrSg5ckeVrzj6wVDFptSmzD8U6tRiZrr3ndXfMvK2y3ina-83Mt--swhqiRrxDnRj141g2jG6NvUzp3xQKn4AQE8Ie35X6t8t1uQsqOQFjfA7liDJ0AUaSvjuTj44oqXWIEjiH4w_W7fgpX944OB8lgf3jwCK5xeqVSJWdtw1Y5W7jHcNmeleP57Ell7wy-XLSp_AQmR5IV
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61BVW98IYGCiwSjwOyYq-93vUBIUSJqNpGOYDUm_Gu1zRVYpfEKcpf49cx41cJoIhLD-S6692N_c3LnvkG4Dk3SShMYh30bRMn0CnqQZlGjoqkMEYIFerqSR_J4VCdnESjDfjR1sJQWmWrEytFnRaG3pH3uS_R2adKyX7WpEWM9gdvz7851EGKvrS27TRqiBza5XcM3-ZvDvbxWb_gfPDh0_uPTtNhwNEYiJROFkgrjBe61k-VEJmOXC1VkqEPoxNXGO2LyFruZZxrY7MgSzBC0p5IUSwMhv8-rrsJ12QgBEnXMR91VkC13frQCggZRG3Bjh_2vy7Ks3yC-PQiKl4OiZ14U0_PVk3jH_7u72mbv9jBwc3_-Q7eghuN983e1eJyGzZsfge2j5v8grtwSmkvTkodD2q2EmaWZTGlrmOGJQ1_CysyRlzfZCtoBsnNjBEVFooyy4sLO2FVQQ41MqLJCZVCL6a4ORtX5Tjl8h58vpL_eR-28iK3u8AwSIsUerZSEaN8murQctco3Eb5uGjUg1cIhrjRJfO4CtP8MK5hExNs4ho2PXhJM89rXpK1E70WWbFpuN-pBclk7TWvu2v-ZYe9FnSXJ79E3F-H0XUN3Qjj37AHz7phVG_0zSrJbbHAJTgFCPjD2_Kghn93Gp-yJjDc74FcEYxuAlGnr47k49OKQl2iZ46u-cP1p34K2ygh8dHB8PAR7HB601LlbO3BVjlb2Mdw3VyU4_nsSSX6DL5ctaT8BLAFmuI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-dimensional+cytometric+analysis+of+colorectal+cancer+reveals+novel+mediators+of+antitumour+immunity&rft.jtitle=Gut&rft.au=de+Vries%2C+Natasja+L&rft.au=van+Unen%2C+Vincent&rft.au=Ijsselsteijn%2C+Marieke+E&rft.au=Abdelaal%2C+Tamim&rft.date=2020-04-01&rft.issn=0017-5749&rft.eissn=1468-3288&rft.volume=69&rft.issue=4&rft.spage=691&rft.epage=703&rft_id=info:doi/10.1136%2Fgutjnl-2019-318672&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_gutjnl_2019_318672
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-5749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-5749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-5749&client=summon